This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Herebert Y. Meltzer, MD; Ramesh C. Arora, PhD; Riaz Babar, MD; Herbert Jackman, PhD; Suhayl Nasr, MD; Gordon Pscheidt, PhD; Mary Smith, MA; Meir Strahilevitz, MD
Department of Psychiatry University of Chicago Pritzker School of Medicine 950 E 59th St Chicago, IL 60637 Illinois State Psychiatric Institute 1601 W Taylor St Chicago, IL 60612

Arch Gen Psychiatry. 1980;37(3):357.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Bond, Cundall, and Falloon¹ recently reported that plate-let monoamine oxidase (MAO) activity in 15 newly admitted schizophrenics was not significantly different from that of 15 controls, but that those with auditory hallucinations (N = 4) had less MAO activity than those who did not (N = 11). Mann and Thomas² also found no difference in platelet MAO activity between 55 schizophrenics and five controls but found no difference in platelet MAO activity between schizophrenics with definite hallucinations (N = 31) and those without hallucinations (N = 2). We calculated that the incidence of hallucinations in the two populations of schizophrenics was significantly different (X² = 16.81, P <.001). This suggests that the two studies were based on different types of schizophrenic populations or different means of determining the presence or absence of hallucinations.

Schildkraut et al³ and we⁴ reported that schizophrenics who hallucinated had significantly less platelet . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?